NO20056207L - Sammensetning for vaksinering av hunder - Google Patents

Sammensetning for vaksinering av hunder

Info

Publication number
NO20056207L
NO20056207L NO20056207A NO20056207A NO20056207L NO 20056207 L NO20056207 L NO 20056207L NO 20056207 A NO20056207 A NO 20056207A NO 20056207 A NO20056207 A NO 20056207A NO 20056207 L NO20056207 L NO 20056207L
Authority
NO
Norway
Prior art keywords
cynos
dogs
attenuated
dog
raising
Prior art date
Application number
NO20056207A
Other languages
English (en)
Inventor
John Brownlie
Victoria Jane Chalker
Kerstin Erles
Original Assignee
Royal Veterinary College
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Royal Veterinary College filed Critical Royal Veterinary College
Publication of NO20056207L publication Critical patent/NO20056207L/no

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/118—Chlamydiaceae, e.g. Chlamydia trachomatis or Chlamydia psittaci
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/295—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Chlamydiales (o)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/30—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Mycoplasmatales, e.g. Pleuropneumonia-like organisms [PPLO]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/315—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Streptococcus (G), e.g. Enterococci
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/12—Pulmonary diseases

Abstract

Vaksineblanding for vaksinering av hunder omfatter (a) et middel med evne til å aktivere en immunrespons mot Streptococcus equi sub species zooepidemicus i en hund, (b) et middel med evne til å aktivere en immunrespons mot Mycoplasma cynos i en hund, og (c) et middel med evne til å aktivere en immunrespons mot Chlamydophila i en hund.
NO20056207A 2003-07-01 2005-12-27 Sammensetning for vaksinering av hunder NO20056207L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0315323.6A GB0315323D0 (en) 2003-07-01 2003-07-01 Vaccine composition
PCT/GB2004/002865 WO2005002618A1 (en) 2003-07-01 2004-07-01 Vaccine composition for vaccinating dogs against canine infectious respiratory disease (cird)

Publications (1)

Publication Number Publication Date
NO20056207L true NO20056207L (no) 2006-01-31

Family

ID=27676393

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20056207A NO20056207L (no) 2003-07-01 2005-12-27 Sammensetning for vaksinering av hunder

Country Status (20)

Country Link
US (3) US8329194B2 (no)
EP (2) EP2050463B1 (no)
JP (1) JP5698890B2 (no)
KR (1) KR20060106809A (no)
CN (1) CN1845754A (no)
AT (1) ATE442857T1 (no)
AU (1) AU2004253344B2 (no)
BR (1) BRPI0412194A (no)
CA (1) CA2530797C (no)
DE (1) DE602004023196D1 (no)
DK (1) DK2050463T3 (no)
ES (2) ES2432175T3 (no)
GB (1) GB0315323D0 (no)
MX (1) MXPA06000278A (no)
NO (1) NO20056207L (no)
NZ (1) NZ544453A (no)
PT (1) PT2050463E (no)
RU (1) RU2006102863A (no)
WO (1) WO2005002618A1 (no)
ZA (1) ZA200600918B (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11865172B2 (en) 2005-04-21 2024-01-09 University Of Florida Research Foundation, Inc. Materials and methods for respiratory disease control in canines
US7682619B2 (en) 2006-04-06 2010-03-23 Cornell Research Foundation, Inc. Canine influenza virus
CN100388952C (zh) * 2006-04-25 2008-05-21 范红结 一种链球菌重组亚单位疫苗及其制备方法
KR101192127B1 (ko) * 2006-11-03 2012-10-17 쉐링-프라우 리미티드 개 라임병 백신
CN102791287A (zh) * 2010-03-10 2012-11-21 英特维特国际股份有限公司 用于保护免于二级病原体引起的疾病的方法
CN103561763A (zh) * 2011-02-04 2014-02-05 佐蒂斯有限责任公司 免疫原性支气管炎博德特氏菌组合物
BR112013019850B1 (pt) * 2011-02-04 2023-02-28 Zoetis Services Llc Composições de vacina e seu uso no tratamento ou prevenção de doenças respiratórias infecciosas caninas
NZ701930A (en) 2012-05-31 2016-10-28 Zoetis Llc Vaccination with canine respiratory coronavirus for protection against b. bronchiseptica infections
CN111499702B (zh) * 2020-05-07 2021-04-06 山东畜牧兽医职业学院 一种马链球菌兽疫亚种的检测试剂盒及检测方法

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8205892D0 (sv) 1982-10-18 1982-10-18 Bror Morein Immunogent membranproteinkomplex, sett for framstellning och anvendning derav som immunstimulerande medel och sasom vaccin
US4567043A (en) * 1983-06-15 1986-01-28 American Home Products Corporation (Del.) Canine corona virus vaccine
US4567042A (en) * 1983-06-15 1986-01-28 American Home Products Corporation Inactivated canine coronavirus vaccine
GB8426468D0 (en) * 1984-10-19 1984-11-28 Technology Licence Co Ltd Monoclonal antibodies
SE8405493D0 (sv) 1984-11-01 1984-11-01 Bror Morein Immunogent komplex samt sett for framstellning derav och anvendning derav som immunstimulerande medel
GB8517895D0 (en) * 1985-07-16 1985-08-21 Technology Licence Co Ltd Monoclonal antibodies
EP0231039B1 (en) 1986-01-14 1992-01-08 De Staat Der Nederlanden Vertegenwoordigd Door De Minister Van Welzijn, Volksgezondheid En Cultuur Process for preparing immunological complexes and pharmaceutical composition containing these complexes
US4806352A (en) 1986-04-15 1989-02-21 Ribi Immunochem Research Inc. Immunological lipid emulsion adjuvant
US4944942A (en) * 1987-08-27 1990-07-31 Mobay Corporation Intranasal vaccination of horses with inactivated microorganisms or antigenic material
US4944972A (en) * 1987-12-31 1990-07-31 American National Can Company Coextrusion apparatus, methods, and related films and packages
US5672350A (en) 1989-08-22 1997-09-30 Veterinary Infectious Disease Organization Recombinant bovine coronavirus E2 and E3 polypeptides and vaccines
US5178860A (en) * 1989-09-01 1993-01-12 Coopers Animal Health Limited Adjuvant complexes and vaccine made therefrom
GB8919819D0 (en) * 1989-09-01 1989-10-18 Coopers Animal Health Complexes having adjuvant activity
US5583014A (en) * 1990-07-03 1996-12-10 Bayer Corporation Preparation and use of enzyme-detergent extracted Streptococcus zoopidemicus vaccine
US6057436A (en) 1990-11-14 2000-05-02 Pfizer Inc. Canine coronavirus S gene and uses therefor
NZ240558A (en) 1990-11-14 1994-11-25 Smithkline Beecham Corp Recombinant feline coronavirus s proteins useful in diagnosis and vaccination against feline peritonitis virus disease
US6372224B1 (en) 1990-11-14 2002-04-16 Pfizer Inc. Canine coronavirus S gene and uses therefor
PT510773E (pt) * 1991-04-25 2004-04-30 Akzo Nobel Nv Vacina subunidade do coronavirus canino
DE4134297A1 (de) * 1991-10-17 1993-04-22 Behringwerke Ag Monoclonale antikoerper gegen mycoplasma pneumoniae, diese produzierende hybridome, verfahren zu deren herstellung sowie deren verwendung
ATE225805T1 (de) 1992-05-08 2002-10-15 Pfizer Hundecoronavirus s gen und verwendung davon
US5750112A (en) 1993-02-26 1998-05-12 Solvay Animal Health, Inc. Canine coronavirus vaccine from feline enteric coronavirus
DK0744937T3 (da) * 1994-02-18 2002-10-28 Solidose L L C Vaccination af dyr med tørrede, pelleterede biologiske materialer
DE69633233T2 (de) 1995-06-12 2005-08-11 Kansas State University Research Foundation, Manhattan Multivalenter impstoff gegen bovines coronavirus und methode zur behandlung einer infektion mit bovinem coronavirus
US5753235A (en) * 1996-02-15 1998-05-19 Heska Corporation Recombinant canine herpesviruses
AU7431796A (en) 1996-10-11 1998-05-11 Human Genome Sciences, Inc. Brain-associated inhibitor of tissue-type plasminogen activator
US6080725A (en) * 1997-05-20 2000-06-27 Galenica Pharmaceuticals, Inc. Immunostimulating and vaccine compositions employing saponin analog adjuvants and uses thereof
US6682745B1 (en) * 1998-07-28 2004-01-27 Christiaan Antonius Arnoldus Jacobs Use of bacterium for manufacture of a vaccine
WO1999025838A1 (en) 1997-11-14 1999-05-27 University Of Georgia Research Foundation, Inc. Compositions and methods to prevent turkey enteritis
US6248329B1 (en) * 1998-06-01 2001-06-19 Ramaswamy Chandrashekar Parasitic helminth cuticlin nucleic acid molecules and uses thereof
DK1023903T3 (da) * 1999-01-26 2004-05-10 Akzo Nobel Nv Anvendelse af levende, svækkede bakterier til fremstilling af en submukös vaccine
US20010048927A1 (en) 2000-02-01 2001-12-06 Richard Stephens Porin B (PorB) as a therapeutic target for prevention and treatment of infection by chlamydia
US6548069B2 (en) * 2001-02-03 2003-04-15 Hmv Associates, Inc. Multivalent Mycoplasma bacterin
US7914799B2 (en) * 2001-08-27 2011-03-29 Immunitor USA, Inc. Anti-fungal composition
GB0217434D0 (en) 2002-07-27 2002-09-04 Royal Vetinary College Biological material
EP1560594B1 (en) 2002-10-11 2010-06-16 GUSS, Bengt Antigenic compositions for immunization of non-human mammals against streptococcus equi
US7793433B2 (en) * 2006-07-14 2010-09-14 Footbalance System Oy Individually formed footwear and a related method

Also Published As

Publication number Publication date
EP2050463B1 (en) 2013-08-21
AU2004253344A1 (en) 2005-01-13
CA2530797A1 (en) 2005-01-13
US20080220018A1 (en) 2008-09-11
EP1638599A1 (en) 2006-03-29
GB0315323D0 (en) 2003-08-06
ES2432175T3 (es) 2013-12-02
US20070098739A1 (en) 2007-05-03
RU2006102863A (ru) 2006-09-10
ATE442857T1 (de) 2009-10-15
US8329194B2 (en) 2012-12-11
DE602004023196D1 (de) 2009-10-29
EP2050463A2 (en) 2009-04-22
EP1638599B1 (en) 2009-09-16
CN1845754A (zh) 2006-10-11
EP2050463A3 (en) 2010-01-20
BRPI0412194A (pt) 2006-08-22
CA2530797C (en) 2014-08-26
MXPA06000278A (es) 2006-04-07
US20110059128A1 (en) 2011-03-10
KR20060106809A (ko) 2006-10-12
JP2007526884A (ja) 2007-09-20
AU2004253344B2 (en) 2010-04-29
WO2005002618A1 (en) 2005-01-13
ZA200600918B (en) 2007-07-25
ES2356396T3 (es) 2011-04-07
DK2050463T3 (da) 2013-09-02
NZ544453A (en) 2009-04-30
JP5698890B2 (ja) 2015-04-08
PT2050463E (pt) 2013-10-29

Similar Documents

Publication Publication Date Title
NO20056207L (no) Sammensetning for vaksinering av hunder
DK1881845T3 (da) Nipah-virusvacciner
MX2009006178A (es) Vacuna contra salmonela.
AR047581A1 (es) Vacunas de calicivirus felino
RU2021112503A (ru) Поливалентная вакцина против м. hyo и её применение
WO2007140244A3 (en) Vaccination of young animals against lawsonia intracellularis infections
Scheerlinck et al. Particulate delivery systems for animal vaccines
DE60115051D1 (de) Immunologische adjuvans verbindungen
AR065765A1 (es) Composicion de vacuna para el tratamiento de enfermedades infecciosas respiratorias
ATE495758T1 (de) Virulentes systemisches felines calicivirus
Frank et al. The probability of severe disease in zoonotic and commensal infections
AR019785A1 (es) Pestivirus no diseminantes
AU2003294192A8 (en) Inclusion bodies as antigens for the oral vaccination of animals
WO2004043286A3 (en) Use of rmlt as a marker antigen for vaccines and as a synergistic adjuvant with amphigen
Steinaa Gene editing in veterinary vaccine development: Status of the science
TH95334A (th) การใช้ของวัคซีนสำหรับการรักษา/การป้องกันของการแพร่เชื้อของจุลชีพก่อโรค
ATE540693T1 (de) Impfung und impfstoffe gegen hundeherpesvirus
Henry Rabies in Asia: 2004
TH95334B (th) การใช้ของวัคซีนสำหรับการรักษา/การป้องกันของการแพร่เชื้อของจุลชีพก่อโรค
Creevy Canine flu: status report and vaccine update.
TH87147A (th) วัคซีนสำหรับการทำให้เกิดภูมิคุ้มกันที่ต้านเชื้อเฮลิโคแมคเตอร์
Yang et al. Clinical Experimental Vaccine Research
AR061201A1 (es) Vacunacion de animales jovenes contra infecciones por lawsonia intracellularis
Miroslav et al. Anthrax Vaccines
Stricker et al. Assessment and verification of the efficacy of the simultaneous use of porcilis M Hyo and Porcilis PRRS in a field study.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application